Tag Archives: Therapy

Triple therapy helps control severe asthma

Asthma affects approximately 20 million adults in the US. It is a common cause of workplace and school absenteeism, and is one of the leading causes of hospitalizations in the US. Between 5% and 10% of asthmatics have frequent, persistent symptoms despite treatment with multiple medications, and are categorized as “difficult to treat” and “severe”… Read More »

When to erectile dysfunction therapy

He or she may ask about problems in your relationship with a partner. Men most often start having sex with their penile implants by eight weeks after surgery. Alprostadil urethral suppository. Surgery penile implant. It’s of great value to have the first shot in the doctor’s office before doing this on your own. Physical activity… Read More »

Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries

After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production. Through a series of licensing agreements with generics makers, Gilead has taken the first steps to build that network.  Gilead signed nonexclusive licensing agreements with five generic drug makers operating in India and… Read More »

Alzheimer’s patients isolated due to coronavirus find support in virtual therapy

The Alzheimer’s Foundation of America (AFA) was founded in 2002 with the goal of providing a community for individuals, families and caregivers affected by Alzheimer’s disease and related dementias. As coronavirus isolates millions of Americans across the country, the AFA is working harder than ever to ensure that some of our nation’s most vulnerable still… Read More »

FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »

Inside Regeneron’s R&D war room, sleepless nights and ‘esprit de corps’ in hunt for COVID-19 therapy

In a few short weeks, the novel coronavirus pandemic has upturned countries around the world, presenting new and complex workplace challenges. That shift is also true for drugmakers working to combat COVID-19.   For New York-based Regeneron––at the forefront of the COVID-19 hunt––those challenges are unprecedented and extraordinary, but it’s still mostly business as usual.  After… Read More »